Zobrazeno 1 - 7
of 7
pro vyhledávání: '"David Chuquin"'
Autor:
Sherin M. Menachery, MD, David Chuquin, MD, Ariel Sindel, DO, Andrew Poklepovic, MD, Antonio Abbate, MD, PhD, Wendy Bottinor, MD, MSCI
Publikováno v:
CJC Open, Vol 5, Iss 2, Pp 170-172 (2023)
Externí odkaz:
https://doaj.org/article/aadbd2af1a05463dbbf4b060820b2617
Autor:
Alessandra Vecchié, Georgia Thomas, Edoardo Bressi, Aldo Bonaventura, Justin M. Canada, David Chuquin, Dinesh Kadariya, Usman Piracha, Delia Endicott, Roshanak Markley, Amir Toor, Michael Hess, Antonio Abbate
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-11 (2021)
Abstract Background Hematopoietic cell transplantation (HCT) is an established and potentially curative therapeutic option for hematologic cancers. HCT survivors are at risk of developing long-term complications impacting on morbidity and mortality.
Externí odkaz:
https://doaj.org/article/078f38647efb4b74ae18aaeebe8d3fa2
Publikováno v:
Journal of Cardiovascular Pharmacology.
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among cancer survivors. Hypertension, which is common among cancer survivors with a prevalence of greater than 70% by age 50, potentiates the risk for CVD in a more than addit
Publikováno v:
The American Journal of Emergency Medicine. 67:197.e3-197.e5
Autor:
Sunil Saith, Alexa Kahn, Hannah Every, Hajira Basit, Anuragh Trikha, Jung-eun Ha, Umair Jangda, Ciril Khorolsky, Jose David Chuquin, Tamta Chkhikvadze
Publikováno v:
Journal of Cardiac Failure. 29:588
Autor:
Ericka Miller, Yiwei Hang, Sherin Menachery, David Chuquin, Xiaoyan Deng, Dipankar Bandyopadhyay, Jennifer H. Jordan, Uyen T. Truong, Madhu Gowda, Wendy Bottinor
Publikováno v:
Journal of the American College of Cardiology. 81:2218
Autor:
Delia Endicott, Amir A. Toor, David Chuquin, Alessandra Vecchié, Justin M. Canada, Edoardo Bressi, Dinesh Kadariya, Usman Ghani Piracha, Aldo Bonaventura, Michael L. Hess, Roshanak Markley, Georgia K. Thomas, Antonio Abbate
Publikováno v:
Cardio-oncology
Cardio-Oncology, Vol 7, Iss 1, Pp 1-11 (2021)
Cardio-Oncology, Vol 7, Iss 1, Pp 1-11 (2021)
Background Hematopoietic cell transplantation (HCT) is an established and potentially curative therapeutic option for hematologic cancers. HCT survivors are at risk of developing long-term complications impacting on morbidity and mortality. Orthostat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc575210cf9012266fcfbc57daaf1bad
http://hdl.handle.net/11567/1065422
http://hdl.handle.net/11567/1065422